A study, which is published in Nature Medicine, has potential implications for earlier diagnoses and future ALS treatments. Their results suggest a correlation between elevated levels of the protein marker SPP1 for perivascular fibroblasts and an aggressive disease process and shorter survival. Results indicate that vascular events are a factor in the disease’s heterogeneity and can improve the knowledge of early stage ALS.
I’m always encouraged when I read an article that includes the text “…this is the first time…” It tells me that research is uncovering new understandings of the disease.
https://news.cision.com/karolinska-institutet/r/new-type-of-cell-contributes-to-increased-understanding-of-als,c3325955
Richard